STOCKHOLM, 21 April 2023 – In the light of the publication of thre results from the clinical trial PHSU05, Promore Pharma AB (publ) invites to a webcast on Friday 21 April kl 10.00
On Friday 21 April at 10.00 CET, the company will host a webcast telephone conference with President and CEO Jonas Ekblom. After the presentation there will be a Q&A session. The conference call will be held in English and can be accessed via computer, tablet, or telephone.
The number of attendees is limited, please register for the conference in advance on the following link:
The conference call will be recorded and made available on the company´s website after the call, and on Västra Hamnen Corporate Finance Youtube channel.